Literature DB >> 15464689

Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.

Mohammed W Akhter1, Doron Aronson, Fahed Bitar, Salman Khan, Harpreet Singh, Rajinder P Singh, Andrew J Burger, Uri Elkayam.   

Abstract

Renal insufficiency (RI), as represented by elevated serum creatinine (>1.5 mg/dl) on admission, is common and found in almost half of patients hospitalized with decompensated heart failure. This finding is associated with prolongation of length of stay and rate of rehospitalizations after discharge and also has an independent unfavorable effect on 6-month mortality. Similarly, an increase in serum creatinine (>0.5 mg/dl) in the hospital results in a significantly longer length of stay and has an independent effect on long-term mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464689     DOI: 10.1016/j.amjcard.2004.06.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  41 in total

1.  Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions.

Authors:  Jeffrey M Testani; Brian D McCauley; Jennifer Chen; Michael Shumski; Richard P Shannon
Journal:  Cardiology       Date:  2010-08-03       Impact factor: 1.869

Review 2.  Cardiorenal syndrome: still not a defined entity.

Authors:  Carlo Longhini; Christian Molino; Fabio Fabbian
Journal:  Clin Exp Nephrol       Date:  2010-02-20       Impact factor: 2.801

3.  Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Authors:  Pedro J Flores-Blanco; Sergio Manzano-Fernández; Juan I Pérez-Calvo; Francisco J Pastor-Pérez; Francisco J Ruiz-Ruiz; Francisco J Carrasco-Sánchez; José L Morales-Rull; Domingo Pascual-Figal; Luis Galisteo-Almeda; James L Januzzi
Journal:  Clin Cardiol       Date:  2015-02-06       Impact factor: 2.882

Review 4.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Andrew Ambrosy; Michael Böhm; Umberto Campia; John G F Cleland; Francesco Fedele; Gregg C Fonarow; Aldo P Maggioni; Alexandre Mebazaa; Mandeep Mehra; Marco Metra; Savina Nodari; Peter S Pang; Piotr Ponikowski; Hani N Sabbah; Michel Komajda; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

6.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

7.  A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure.

Authors:  Andrew K Roy; Catherine Mc Gorrian; Cecelia Treacy; Edel Kavanaugh; Alice Brennan; Niall G Mahon; Patrick T Murray
Journal:  Cardiorenal Med       Date:  2013-02-26       Impact factor: 2.041

8.  Predictors of re-hospitalization in patients with chronic heart failure.

Authors:  Melody Zaya; Anita Phan; Ernst R Schwarz
Journal:  World J Cardiol       Date:  2012-02-26

9.  Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.

Authors:  Uptal D Patel; Melissa A Greiner; Gregg C Fonarow; Hemant Phatak; Adrian F Hernandez; Lesley H Curtis
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

10.  Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.

Authors:  Mostafa El-Refai; Olesya Krivospitskaya; Edward L Peterson; Karen Wells; L Keoki Williams; David E Lanfear
Journal:  J Clin Exp Cardiolog       Date:  2011-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.